Royal Bank of Canada »

Neurocrine Biosciences shares owned by Royal Bank of Canada

Quarter-by-quarter ownership of Neurocrine Biosciences (NBIX) shares owned by Royal Bank of Canada from 13F filings

Historical chart of Royal Bank of Canada investment in Neurocrine Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Neurocrine Biosciences held by Royal Bank of Canada consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Neurocrine Biosciences by Royal Bank of Canada

Quarter filed Position value Share count Share price at filing
2011-09-30 $43k 4.9k 8.62
2011-06-30 $19k 2.2k 8.62

More positions owned by Royal Bank of Canada

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Microsoft Corporation (MSFT)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Toronto Dominion Bk Ont Com New (TD)
Rbc Cad (RY)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Ishares Tr Core S&p500 Etf (IVV)
Bk Nova Cad (BNS)
Ishares Tr Russell 2000 Etf (IWM)
Bank Of Montreal Cadcom (BMO)
JPMorgan Chase & Co. (JPM)
Enbridge (ENB)
Cibc Cad (CM)

View all positions for Royal Bank of Canada

Top funds holding Neurocrine Biosciences

BlackRock
BlackRock
Vanguard Group
State Street Corporation
Renaissance Technologies
Bellevue Group
Geode Capital Management
Citadel Advisors
AQR Capital Management
T. Rowe Price Associates
Morgan Stanley
Jpmorgan Chase & Co
Deerfield Management Company
Dodge & Cox
Goldman Sachs Group

View all funds holding Neurocrine Biosciences